Literature DB >> 31626900

Revealing new landscape of cardiovascular disease through circular RNA-miRNA-mRNA axis.

Qiang Su1, Xiangwei Lv2.   

Abstract

Non-coding RNA (ncRNA) is a kind of RNA, produced by genomic transcription and does not encode protein, but can regulate the function of genes, thus widely regulating pathological and physiological processes. The dynamic balance of the reticular structure between them is needed to regulate the homeostasis, the abnormal regulation of one of them may lead to the occurrence of the disease. CircRNA is mainly involved in the evolution of CVD through sponge-like regulation of miRNAs, subsequently regulating miRNAs and their targets, mRNA functions. The role of circRNA-miRNA-mRNA axis in pathogenesis of cardiovascular diseases has been recently reported and highlighted. In this review, the emerging roles of circRNA-miRNA-mRNA axis in cardiovascular pathophysiology and regulation were discussed, with a novel focus on cardioprotective network activities of the circRNA.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiovascular diseases; CeRNA; CircRNA; MiRNA

Mesh:

Substances:

Year:  2019        PMID: 31626900     DOI: 10.1016/j.ygeno.2019.10.006

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  31 in total

Review 1.  Non-Coding RNA Networks as Potential Novel Biomarker and Therapeutic Target for Sepsis and Sepsis-Related Multi-Organ Failure.

Authors:  Domenico Di Raimondo; Edoardo Pirera; Giuliana Rizzo; Irene Simonetta; Gaia Musiari; Antonino Tuttolomondo
Journal:  Diagnostics (Basel)       Date:  2022-05-31

2.  Circular RNA circ_0001445 alleviates the ox-LDL-induced endothelial injury in human primary aortic endothelial cells through regulating ABCG1 via acting as a sponge of miR-208b-5p.

Authors:  Zhihua Yang; Xing Liang; Lixia Yang
Journal:  Gen Thorac Cardiovasc Surg       Date:  2022-04-07

3.  Circ_0000885 Enhances Osteosarcoma Progression by Increasing FGFR1 Expression via Sponging MiR-1294.

Authors:  Yinxian Chen; Sicheng Zhang; Chuanqing Bai; Zhiye Guan; Wenjian Chen
Journal:  Cancer Manag Res       Date:  2020-07-28       Impact factor: 3.989

4.  Circular RNA ZNF609 Promoted Hepatocellular Carcinoma Progression by Upregulating PAP2C Expression via Sponging miR-342-3p.

Authors:  Xin Liao; Wei Zhan; Bin Tian; Yilin Luo; Fang Gu; Rui Li
Journal:  Onco Targets Ther       Date:  2020-08-04       Impact factor: 4.147

5.  Exosomal Circ-XIAP Promotes Docetaxel Resistance in Prostate Cancer by Regulating miR-1182/TPD52 Axis.

Authors:  Hui Zhang; Minghui Li; Jing Zhang; Yanbing Shen; Qi Gui
Journal:  Drug Des Devel Ther       Date:  2021-05-03       Impact factor: 4.162

Review 6.  Circular RNAs are a novel type of non-coding RNAs in ROS regulation, cardiovascular metabolic inflammations and cancers.

Authors:  Fatma Saaoud; Charles Drummer I V; Ying Shao; Yu Sun; Yifan Lu; Keman Xu; Dong Ni; Xiaohua Jiang; Hong Wang; Xiaofeng Yang
Journal:  Pharmacol Ther       Date:  2020-10-24       Impact factor: 12.310

7.  GATCDA: Predicting circRNA-Disease Associations Based on Graph Attention Network.

Authors:  Chen Bian; Xiu-Juan Lei; Fang-Xiang Wu
Journal:  Cancers (Basel)       Date:  2021-05-25       Impact factor: 6.639

8.  Quercetin prevents isoprenaline-induced myocardial fibrosis by promoting autophagy via regulating miR-223-3p/FOXO3.

Authors:  Jiqiang Hu; Xuan Wang; Xiaoyun Cui; Wu Kuang; Dong Li; Jing Wang
Journal:  Cell Cycle       Date:  2021-06-07       Impact factor: 5.173

9.  Hsa_circ_0008360 sponges miR-186-5p to target CCND2 to modulate high glucose-induced vascular endothelial dysfunction.

Authors:  Qian-Qian Zhu; Xi-Bin Pu; Tian-Chi Chen; Chen-Yang Qiu; Zi-Heng Wu; Lu Tian; Yang-Yan He; Xiao-Hui Wang; Tao Shang; Xun Wang; Yi-Lang Xiang; Dong-Lin Li; Hong-Kun Zhang
Journal:  Cell Cycle       Date:  2021-07-05       Impact factor: 5.173

10.  CircPSMC3 alleviates the symptoms of PCOS by sponging miR-296-3p and regulating PTEN expression.

Authors:  Jun Liu; Jinli Ding; Bing Qu; Jiuying Liu; Xiaojie Song; Qingli Suo; Aifen Zhou; Jing Yang
Journal:  J Cell Mol Med       Date:  2020-08-17       Impact factor: 5.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.